BD 231609 - BBL Sensi-Disc Piperacillin 100mcg Reliable Antimicrobial Susceptibility Testing for Gram-Negative Bacteria, 10CR/BX
The BD 231609 BBL Sensi-Disc Piperacillin 100mcg is a high-quality antimicrobial susceptibility testing (AST) reagent designed for standardized disk diffusion methods such as the Kirby-Bauer technique. Each sterile paper disk contains 100 micrograms of piperacillin, a broad-spectrum penicillin antibiotic widely used against Gram-negative and selected Gram-positive organisms. Manufactured under BDs strict quality standards, these Sensi-Discs provide consistent, reproducible diffusion characteristics, enabling accurate determination of bacterial susceptibility and supporting clinical decisions in antimicrobial therapy.
| Manufacturer | Application | Storage Requirements |
| 231609 | Antimicrobial Susceptibility Testing Disc | Requires Refrigeration |
Key Benefits
The BD 231609 Piperacillin 100mcg Sensi-Disc ensures exceptional accuracy and reproducibility in laboratory testing. Each disk contains a precisely measured antibiotic concentration for uniform diffusion and consistent inhibition zone formation. The sterile, single-use format minimizes contamination risks and supports aseptic laboratory workflow. By providing standardized and validated performance, these Sensi-Discs allow clinicians to accurately assess bacterial resistance patterns and guide appropriate antibiotic therapy. The products stability and precision make it a trusted choice for clinical microbiology laboratories worldwide.
Compatibility and Applications
The BD 231609 Sensi-Disc is compatible with standard Mueller-Hinton agar and adheres to CLSI (Clinical and Laboratory Standards Institute) and EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. It is primarily used for Gram-negative organisms, including Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., and Proteus spp. Piperacillins broad antimicrobial activity makes this disk ideal for use in hospital laboratories, public health facilities, and research centers conducting routine susceptibility testing and resistance monitoring.
Usage Guidelines
Perform the disk diffusion test following CLSI or EUCAST-approved protocols. Prepare a standardized bacterial inoculum equivalent to 0.5 McFarland turbidity and inoculate evenly on Mueller-Hinton agar plates. Place the BD 231609 Piperacillin 100mcg disk aseptically on the inoculated surface using sterile forceps or a disk dispenser. Incubate the plate at 3537C for 1618 hours. Measure the inhibition zone diameter and interpret results using established CLSI breakpoints. Store disks at 28C in a dry, dark environment and allow them to reach room temperature before use to avoid condensation and potency loss.
Certifications, Safety Standards, and Regulatory Approvals
The BD 231609 Piperacillin Sensi-Disc is produced under ISO 9001 and ISO 13485 certified quality management systems. It meets FDA and CE regulatory requirements for in vitro diagnostic (IVD) medical devices. Each batch is subjected to stringent quality control testing for antibiotic potency, diffusion uniformity, and sterility, ensuring full compliance with international microbiological performance standards. BDs globally recognized manufacturing processes guarantee consistency and reliability in every lot.
Comparison with Competitor Products
Compared to generic antibiotic disks, BDs Sensi-Discs deliver superior reproducibility, stability, and reliability. Competitor products often show variable antibiotic concentrations or inconsistent diffusion rates, which can compromise test accuracy. BDs proprietary manufacturing technology ensures precise antibiotic impregnation, controlled moisture content, and even diffusion across all disks. The result is improved performance, reduced variability, and enhanced confidence in antimicrobial susceptibility data.
Typical User Profile and Application Scenarios
The BD 231609 Piperacillin 100mcg Sensi-Disc is used by microbiologists, clinical laboratory scientists, and infection control professionals. It is commonly employed in hospital microbiology departments, clinical diagnostic laboratories, pharmaceutical testing units, and public health research facilities. Typical applications include routine antimicrobial susceptibility testing, epidemiological surveillance of resistant strains, and quality control testing in pharmaceutical microbiology.
Best Practices for Use and Maintenance
Always handle disks with sterile forceps and follow aseptic procedures to prevent contamination. Store in tightly sealed containers to protect against humidity and temperature fluctuations. Allow refrigerated disks to reach room temperature before opening the package. Use appropriate control strains such as Pseudomonas aeruginosa ATCC 27853 and Escherichia coli ATCC 25922 to verify test performance. Discard expired or contaminated disks immediately and dispose of used materials according to institutional biohazard protocols.
Regulatory and Safety Information
The BD 231609 Piperacillin 100mcg Sensi-Disc is intended for in vitro diagnostic use by trained laboratory professionals. It complies with FDA, CE, and ISO regulations for antimicrobial testing reagents. Although non-toxic, the disks should be handled under biosafety level 2 (BSL-2) conditions when testing pathogenic bacteria. Use personal protective equipment (PPE) including gloves, lab coats, and protective eyewear, and dispose of all biological waste in accordance with local safety regulations.
How to Order
To order the BD 231609 BBL Sensi-Disc Piperacillin 100mcg, add the product to your cart and proceed through CIA Medicals secure online checkout system. For institutional or bulk purchase inquiries, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page. Our team is available to assist with product availability, technical documentation, and pricing to meet your laboratorys testing needs.
